SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-050441
Filing Date
2013-09-24
Accepted
2013-09-24 19:13:41
Documents
2
Period of Report
2013-09-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd391130.html 4  
1 PRIMARY DOCUMENT rrd391130.xml 4 3673
2 POWER OF ATTORNEY OF RAHUL SINGHVI rrd351902_398441.htm EX-24.1 4879
  Complete submission text file 0001181431-13-050441.txt   10212
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 246 HOLLY DRIVE CHALFONT PA 18914
Business Address
Singhvi Rahul (Reporting) CIK: 0001322731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 131113160